Stem cell properties and the side population cells as a target for interferon-alpha in adult T-cell leukemia/lymphoma.

Abstract

The cancer stem cell theory suggests that chemoresistance and recurrence of tumors are often due to the similarity of stem cell properties between normal and cancer cells. Adult T-cell leukemia/lymphoma (ATLL) has poor prognosis, suggesting that ATLL cells possess common stem cell properties. We analyzed side population (SP), a characteristic stem cell phenotype, and CD markers in ATLL cell lines. We found that several lines contained SP with expressions of some hematopoietic stem cell markers. On the other hand, treatment with interferon (IFN)-alpha is sometimes effective in ATLL, particularly combined with other drugs. We examined its effect on ATLL cells and found that IFN-alpha significantly reduced the SP proportion. Moreover, CD25-positive cells and phosphorylation of STAT1/5 and ERK were upregulated during this process. These data suggest that their stem cell properties render ATLL cells therapy-resistant, and IFN-alpha exerts its clinical effect through a reduction of the SP cell population.

• Authors: Hiroyuki Kayo, Hiroto Yamazaki, Hiroko Nishida, Nam H Dang, Chikao Morimoto
• Journal: Biochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 364 Issue 4 Pg. 808-14 (Dec 28 2007) ISSN: 1090-2104 [Electronic] United States
• PMID: 17977513 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Interferon-alpha
• Neoplasm Proteins

Topics

• Cell Line, Tumor
• Drug Delivery Systems (methods)
• Humans
• Interferon-alpha (administration & dosage)
• Leukemia, T-Cell (metabolism, pathology)
• Neoplasm Proteins (metabolism)
• Stem Cells (drug effects, metabolism, pathology)